Darunavir 300 mg
As a protease inhibitor designed for use in boosted antiretroviral regimens, Darunavir 300 mg Tablets are incorporated into combination therapy strategies for the treatment of HIV-1 infection, following established international treatment guidance.
Product Details
Therapeutic Class
Protease Inhibitor (Antiretroviral)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
300 mg administered with an appropriate pharmacokinetic booster and in combination with other antiretroviral agents, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
120 tablets